» Articles » PMID: 25895968

Anti-Pseudomonas Aeruginosa IgY Antibodies Induce Specific Bacterial Aggregation and Internalization in Human Polymorphonuclear Neutrophils

Overview
Journal Infect Immun
Date 2015 Apr 22
PMID 25895968
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Polymorphonuclear neutrophils (PMNs) are essential cellular constituents in the innate host response, and their recruitment to the lungs and subsequent ubiquitous phagocytosis controls primary respiratory infection. Cystic fibrosis pulmonary disease is characterized by progressive pulmonary decline governed by a persistent, exaggerated inflammatory response dominated by PMNs. The principal contributor is chronic Pseudomonas aeruginosa biofilm infection, which attracts and activates PMNs and thereby is responsible for the continuing inflammation. Strategies to prevent initial airway colonization with P. aeruginosa by augmenting the phagocytic competence of PMNs may postpone the deteriorating chronic biofilm infection. Anti-P. aeruginosa IgY antibodies significantly increase the PMN-mediated respiratory burst and subsequent bacterial killing of P. aeruginosa in vitro. The mode of action is attributed to IgY-facilitated formation of immobilized bacteria in aggregates, as visualized by fluorescence microscopy and the induction of increased bacterial hydrophobicity. Thus, the present study demonstrates that avian egg yolk immunoglobulins (IgY) targeting P. aeruginosa modify bacterial fitness, which enhances bacterial killing by PMN-mediated phagocytosis and thereby may facilitate a rapid bacterial clearance in airways of people with cystic fibrosis.

Citing Articles

Polyclonal anti-whole cell IgY passive immunotherapy shields against P. aeruginosa-induced acute pneumonia and burn wound infections in murine models.

Ahmadi T, Behrouz B, Mousavi Gargari S Sci Rep. 2024; 14(1):405.

PMID: 38172232 PMC: 10764880. DOI: 10.1038/s41598-023-50859-x.


IgY antibodies: The promising potential to overcome antibiotic resistance.

El-Kafrawy S, Abbas A, Oelkrug C, Tahoon M, Ezzat S, Zumla A Front Immunol. 2023; 14:1065353.

PMID: 36742328 PMC: 9896010. DOI: 10.3389/fimmu.2023.1065353.


Chicken IgY reduces the risk of urinary tract infections in a murine model.

Schwartz F, Christophersen L, Thomsen K, Baekdal S, Bendixen M, Jorgensen M Front Microbiol. 2022; 13:988386.

PMID: 36160201 PMC: 9505517. DOI: 10.3389/fmicb.2022.988386.


Immune Response to Biofilm Growing Pulmonary Infection.

Thomsen K, Hoiby N, Jensen P, Ciofu O, Moser C Biomedicines. 2022; 10(9).

PMID: 36140163 PMC: 9495460. DOI: 10.3390/biomedicines10092064.


Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Lee L, Samardzic K, Wallach M, Frumkin L, Mochly-Rosen D Front Immunol. 2021; 12:696003.

PMID: 34177963 PMC: 8220206. DOI: 10.3389/fimmu.2021.696003.


References
1.
Nguyen H, Tumpey T, Park H, Byun Y, Tran L, Nguyen V . Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS One. 2010; 5(4):e10152. PMC: 2854139. DOI: 10.1371/journal.pone.0010152. View

2.
Rosenberg M . Microbial adhesion to hydrocarbons: twenty-five years of doing MATH. FEMS Microbiol Lett. 2006; 262(2):129-34. DOI: 10.1111/j.1574-6968.2006.00291.x. View

3.
Kerosuo E, Haapasalo M, Alli K, Lounatmaa K . Ingestion of Bacteroides buccae, Bacteroides oris, Porphyromonas gingivalis, and Fusobacterium nucleatum by human polymorphonuclear leukocytes in vitro. Oral Microbiol Immunol. 1990; 5(4):202-7. DOI: 10.1111/j.1399-302x.1990.tb00646.x. View

4.
Shimizu M, Nagashima H, Sano K, Hashimoto K, Ozeki M, Tsuda K . Molecular stability of chicken and rabbit immunoglobulin G. Biosci Biotechnol Biochem. 1992; 56(2):270-4. DOI: 10.1271/bbb.56.270. View

5.
Nauseef W . How human neutrophils kill and degrade microbes: an integrated view. Immunol Rev. 2007; 219:88-102. DOI: 10.1111/j.1600-065X.2007.00550.x. View